Spyre Therapeutics SYRE
$93.47 −$4.16 (-4.26%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $93.47 0.00%
Open$95.93
Prev close$97.63
Day range$93.22 – $99.56
Volume805.4K
Market cap$8.88B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts13
Average target$123.38+32.0% vs. price
- Buy 100%
Low $115.00Now $93.47Avg $123.38High $135.00
Recent rating changes
The last 20 actions on file set price targets from $110.00 to $135.00, averaging $121.60.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | J.P. Morgan | BUY | $116.00 |
| 5 Nov 2026 | Wells Fargo | BUY | $115.00 |
| 4 Nov 2026 | Wells Fargo | BUY | $115.00 |
| 4 Nov 2026 | JonesTrading | BUY | $130.00 |
| 4 Nov 2026 | BTIG | BUY | $121.00 |
| 4 Nov 2026 | Wedbush | BUY | $120.00 |
| 4 Nov 2026 | Stifel | BUY | $131.00 |
| 3 Nov 2026 | Guggenheim | BUY | $135.00 |
| 21 Oct 2026 | Citi | BUY | $119.00 |
| 20 Oct 2026 | Citi | BUY | $119.00 |
| 19 Oct 2026 | BTIG | BUY | $121.00 |
| 19 Oct 2026 | Wedbush | BUY | $123.00 |
| 12 Oct 2026 | UBS | BUY | $120.00 |
| 11 Oct 2026 | UBS | BUY | $120.00 |
| 2 Oct 2026 | Wells Fargo | BUY | $115.00 |
| 1 Oct 2026 | JonesTrading | BUY | $130.00 |
| 1 Oct 2026 | J.P. Morgan | BUY | $110.00 |
| 27 Sep 2026 | JonesTrading | BUY | $121.00 |
| 10 Sep 2026 | Leerink Partners | BUY | $128.00 |
| 9 Sep 2026 | Wedbush | BUY | $123.00 |
No comments yet — be the first to weigh in on SYRE.
Sign in to join the discussion.